Retesting HER2 Status of Axillary Lymph Node Metastases for Breast Cancer Patients with Minor HER2 Amplified Clone in the Primary Tumors: Does it has Clinical Significance?

被引：0
|
作者：
Yang, Jieliang [1 ]
Chen, Min [1 ]
Peng, Heng [1 ]
Zhang, Zhang [1 ]
Wu, Yingyue [1 ]
Wei, Bing [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengu, Chengdu, Peoples R China
来源：
LABORATORY INVESTIGATION | 2025年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.labinv.2024.102483
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
259
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients
    Baros, Ilija Vladimir
    Tanaskovic, Natsa
    Pellas, Ulrika
    Eri, Zivka
    Latinovic, Ljiljana Tadic
    Tot, Tibor
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 19 (03) : 242 - 248
  • [2] Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis
    Zi-xiang Yao
    Lin-jie Lu
    Rui-jue Wang
    Liang-bin Jin
    Sheng-chun Liu
    Hong-yuan Li
    Guo-sheng Ren
    Kai-nan Wu
    De-lin Wang
    Ling-quan Kong
    Medical Oncology, 2014, 31
  • [3] Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis
    Yao, Zi-xiang
    Lu, Lin-jie
    Wang, Rui-jue
    Jin, Liang-bin
    Liu, Sheng-chun
    Li, Hong-yuan
    Ren, Guo-sheng
    Wu, Kai-nan
    Wang, De-lin
    Kong, Ling-quan
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [4] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [5] HER2, estrogen receptor and progesterone receptor status in primary breast carcinomas and paired axillary lymph node metastases
    Desonki, M. M.
    Wolff, D. J.
    Geradts, J.
    Self, S. E.
    MODERN PATHOLOGY, 2008, 21 : 28A - 28A
  • [6] HER2, estrogen receptor and progesterone receptor status in primary breast carcinomas and paired axillary lymph node metastases
    Desonki, M. M.
    Wolff, D. J.
    Geradis, J.
    Self, S. E.
    LABORATORY INVESTIGATION, 2008, 88 : 28A - 28A
  • [7] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [8] Concordance of HER2 Status in Primary Tumour and Lymph Node Metastases in Patients with Esophageal Carcinoma
    Koenig, Alexandra M.
    Reeh, Matthias
    Dancau, Ana-Maria
    Rathjens, Merrit
    Gros, Stephanie
    Uzunoglu, Faik G.
    Bockhorn, Maximilian
    Simon, Ronald
    Sauter, Guido
    Marx, Andreas
    Izbicki, Jakob R.
    ANTICANCER RESEARCH, 2013, 33 (11) : 4975 - 4982
  • [9] HER2/neu overexpression does not predict axillary lymph node metastases in invasive lobular carcinoma of the breast
    Tan, LC
    Kleer, CG
    LABORATORY INVESTIGATION, 2001, 81 (01) : 38A - 38A
  • [10] Clinical significance of metastatic-tumor HER2 status in patients with HER2-positive primary breast cancer
    Niikura, N.
    Liu, J.
    Hayashi, N.
    Mittendorf, E. A.
    Gong, Y.
    Palla, S. L.
    Tokuda, Y.
    Gonzalez-Angulo, A. M.
    Hortobagyi, G. N.
    Ueno, N. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345